Overview
Osamu Kondoh practices practicing medicine in Kamakura, Japan.
His clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Follicular Lymphoma, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.
He is actively involved in clinical research, co-authoring 17 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Osamu Kondoh
Is Osamu Kondoh a top-rated expert for PIK3CA-Related Overgrowth Spectrum?
MediFind is an objective health platform that identifies experts based on real-world data. Osamu Kondoh is classified as an Experienced expert for PIK3CA-Related Overgrowth Spectrum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Osamu Kondoh participate in research or clinical trials?
Yes. Osamu Kondoh has published 17 articles and abstracts on conditions like PIK3CA-Related Overgrowth Spectrum. You can view a list of Osamu Kondoh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Follicular LymphomaMr. Kondoh isExperienced. Learn about Follicular Lymphoma.
- Lung CancerMr. Kondoh isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Kondoh isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- PIK3CA-Related Overgrowth SpectrumMr. Kondoh isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.